跳至主要内容
临床试验/EUCTR2017-001977-18-DK
EUCTR2017-001977-18-DK进行中(未招募)1 期

Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)

niversity Medical Center Groningen0 个研究点开始时间: 2017年5月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Type 2 diabetes
  • eGFR > 45ml/min/1.73m2
  • Albumin:creatinine ratio >50mg/g and =500 mg/g
  • Age = 18 years
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 52
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Pregnant women and women of child-bearing potential who are not using reliable contraception
  • Cardiovascular disease: myocardial infarction, angina pectoris, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, stroke, heart failure (NYHA I-IV) < 6 months before inclusion
  • Uncontrolled blood pressure (office BP > 160/100 mmHg)
  • Active malignancy
  • History of autonomic dysfunction (e.g. history of fainting or clinically significant orthostatic hypotension)

研究者

相似试验